“Cipla Medpro is facing accusations that it failed to adequately warn patients about the potentially severe side effects of a common antibiotic, Tavaloxx, a fluoroquinolone antibiotic. after a Johannesburg man suffered four life-altering tendon ruptures. – BusinessLIVE (5 August 2025)
The patient is considering legal action, claiming that warnings (dated October 2007) provided inside the medicine's box were severely outdated, omitting critical information about risks that have been known globally for years
“Between 2015 and 2018, the US Food and Drug Administration (FDA) issued multiple warnings about risks ranging from tendon ruptures to aortic aneurysms.”
In 2019, Cipla and other pharmaceutical firms in collaboration with the SA Health Products Regulatory Authority (SAHPRA) sent a letter to medical practitioners advising against prescribing the drug for a range of mild-to-moderate or self-limiting infections.